Seguir
Guilherme Dias de Melo
Título
Citado por
Citado por
Ano
COVID-19–related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters
GD De Melo, F Lazarini, S Levallois, C Hautefort, V Michel, F Larrous, ...
Science translational medicine 13 (596), eabf8396, 2021
3912021
SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance
R Robinot, M Hubert, GD de Melo, F Lazarini, T Bruel, N Smith, ...
Nature communications 12 (1), 4354, 2021
1652021
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
YJ Park, D Pinto, AC Walls, Z Liu, A De Marco, F Benigni, F Zatta, ...
Science 378 (6620), 619-627, 2022
1492022
Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
GD de Melo, F Lazarini, F Larrous, L Feige, E Kornobis, S Levallois, ...
EMBO molecular medicine 13 (8), e14122, 2021
592021
Leukocyte entry into the CNS of Leishmania chagasi naturally infected dogs
GD Melo, M Marcondes, RO Vasconcelos, GF Machado
Veterinary parasitology 162 (3-4), 248-256, 2009
422009
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA. 1 and BA. 2
C Planchais, I Fernández, T Bruel, GD de Melo, M Prot, M Beretta, ...
Journal of Experimental Medicine 219 (7), 2022
412022
Neutralization, effector function and immune imprinting of Omicron variants
A Addetia, L Piccoli, JB Case, YJ Park, M Beltramello, B Guarino, H Dang, ...
Nature 621 (7979), 592-601, 2023
392023
Ki-67 labeling in canine perianal glands neoplasms: a novel approach for immunohistological diagnostic and prognostic
RS Pereira, A Schweigert, GD Melo, FV Fernandes, FAR Sueiro, ...
BMC Veterinary Research 9, 1-7, 2013
382013
Levels of matrix metalloproteinase‐2 and metalloproteinase‐9 in the cerebrospinal fluid of dogs with visceral leishmaniasis
NR Marangoni, GD Melo, OC Moraes, MS Souza, SHV Perri, GF Machado
Parasite immunology 33 (6), 330-334, 2011
372011
Anti-COVID-19 efficacy of ivermectin in the golden hamster
GD de Melo, F Lazarini, F Larrous, L Feige, L Kergoat, A Marchio, ...
BioRxiv, 2020.11. 21.392639, 2020
352020
COVID-19-associated olfactory dysfunction reveals SARS-CoV-2 neuroinvasion and persistence in the olfactory system
GD De Melo, F Lazarini, S Levallois, C Hautefort, V Michel, F Larrous, ...
BioRxiv, 2020.11. 18.388819, 2020
342020
Differential alterations in the activity of matrix metalloproteinases within the nervous tissue of dogs in distinct manifestations of visceral leishmaniasis
GF Machado, GD Melo, OC Moraes, MS Souza, M Marcondes, SHV Perri, ...
Veterinary immunology and immunopathology 136 (3-4), 340-345, 2010
342010
New insights into experimental visceral leishmaniasis: Real-time in vivo imaging of Leishmania donovani virulence
GD Melo, S Goyard, H Lecoeur, E Rouault, P Pescher, L Fiette, ...
PLoS neglected tropical diseases 11 (9), e0005924, 2017
322017
Pro-inflammatory cytokines predominate in the brains of dogs with visceral leishmaniasis: a natural model of neuroinflammation during systemic parasitic infection
GD Melo, TF Seraguci, A Schweigert, JES Silva, FG Grano, JR Peiró, ...
Veterinary parasitology 192 (1-3), 57-66, 2013
312013
Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein
J Hellert, J Buchrieser, F Larrous, A Minola, GD de Melo, L Soriaga, ...
Nature communications 11 (1), 596, 2020
302020
High levels of serum matrix metalloproteinases in dogs with natural visceral leishmaniosis: a preliminary report
GD Melo, NR Marangoni, M Marcondes, VMF Lima, GF Machado
The veterinary journal 188 (2), 243-245, 2011
302011
Choroid plexus involvement in dogs with spontaneous visceral leishmaniasis: a histopathological investigation.
GD Melo, GF Machado
302009
Glial reactivity in dogs with visceral leishmaniasis: correlation with T lymphocyte infiltration and with cerebrospinal fluid anti-Leishmania antibody titres
GD Melo, GF Machado
Cell and tissue research 346 (3), 293-304, 2011
282011
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy
GD de Melo, J Hellert, R Gupta, D Corti, H Bourhy
Current opinion in virology 53, 101204, 2022
242022
A combination of two human monoclonal antibodies cures symptomatic rabies
GD de Melo, F Sonthonnax, G Lepousez, G Jouvion, A Minola, F Zatta, ...
EMBO Molecular Medicine 12 (11), e12628, 2020
242020
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20